VAERS reports by lot

Pfizer COVID-19 lot HG2649: VAERS reports

75 VAERS reports list lot HG2649 as a Pfizer COVID-19 vaccine, received between 2023-10-13 and 2024-12-30. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
75
Reports
5%
Marked serious
1
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological6121%
Cardiac / Cardiovascular4817%
General / Systemic (non-local)4516%
Injection-site / Local reaction3713%
Gastrointestinal269%
Musculoskeletal197%
Thrombotic / Hematological135%
Allergic / Anaphylactic114%
Respiratory93%
Dermatological (non-injection-site)93%
Psychiatric / Neuropsychiatric52%
Autoimmune / Immune-mediated31%
Reproductive / Menstrual10%

Where reports came from

U.S. state of the reporter, where given (top 12).

California19
Maryland11
Massachusetts5
Virginia4
Pennsylvania3
North Carolina3
Michigan2
South Carolina2
Oregon2
New York2
Ohio2
Missouri1

Reports by month received

2023-1015
2023-1115
2023-1214
2024-018
2024-024
2024-031
2024-041
2024-0616
2024-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.